Lower is not always better? Blood pressure treatment targets revisited

Journal of the American College of Cardiology

Volumn 64, Issue 6, 2014, Pages 598-600

  Andersson, Charlotte ^a,b   Vasan, Ramachandran S ^a,c,d  

^a FRAMINGHAM HEART STUDY   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

blood pressure; epidemiology; hypertension; treatment targets

Indexed keywords

BLOOD PRESSURE; EPIDEMIOLOGY; HYPERTENSION; TREATMENT TARGETS;

BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; POPULATION SURVEILLANCE;

EID: 84905695232     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.04.066     Document Type: Editorial

References (21)

1. Q. Yang, M.E. Cogswell, and W.D. Flanders et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults JAMA 307 2012 1273 1283
2. A.S. Go, D. Mozaffarian, V.L. Roger for the AHA Statistics Committee and Stroke Statistics Subcommittee Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association Circulation 129 2014 399 410
3. C. Olives, R. Myerson, A.H. Mokdad, C.J. Murray, and S.S. Lim Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009 PloS One 8 2013 e60308
4. L.J. Laslett, P. Alagona Jr., and B.A. Clark 3rd et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology J Am Coll Cardiol 60 Suppl 25 2012 S1 S49
5. M.R. Law, J.K. Morris, and N.J. Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665
6. F. Turnbull for the Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 2003 1527 1535
7. P.A. James, S. Oparil, and B.L. Carter et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2014 507 520
8. J.J. Sim, J. Shi, C.P. Kovesdy, K. Kalantar-Zadeh, and S.J. Jacobsen Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population J Am Coll Cardiol 64 2014 588 597
9. S.S. Franklin, V.A. Lopez, and N.D. Wong et al. Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study Circulation 119 2009 243 250
10. S. Lewington, R. Clarke, N. Qizilbash for the Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
11. B.M. Kaess, J. Rong, and M.G. Larson et al. Aortic stiffness, blood pressure progression, and incident hypertension JAMA 308 2012 875 881
12. S. Strandgaard Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension Circulation 53 1976 720 727
13. J.M. Cruickshank The role of coronary perfusion pressure Eur Heart J 13 Suppl D 1992 39 43
14. U. Lindblad, L. Rastam, L. Ryden, J. Ranstam, S.O. Isacsson, and G. Berglund Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project BMJ 308 1994 681 686
15. O.R. Benavente, C.S. Coffey, R. Conwit for the SP3S Study Group Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial Lancet 382 2013 507 515
16. J.D. Williamson, L.J. Launer, R.N. Bryan for the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Investigators Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial JAMA Intern Med 174 2014 324 333
17. K.J. Mukamal, M. Maclure, J.E. Muller, J.B. Sherwood, and M.A. Mittleman Prior alcohol consumption and mortality following acute myocardial infarction JAMA 285 2001 1965 1970
18. C.J. Currie, J.R. Peters, and A. Tynan et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study Lancet 375 2010 481 489
19. K. Kalantar-Zadeh, K.C. Abbott, A.K. Salahudeen, R.D. Kilpatrick, and T.B. Horwich Survival advantages of obesity in dialysis patients Am J Clin Nutr 81 2005 543 554
20. K. Kalantar-Zadeh, G. Block, T. Horwich, and G.C. Fonarow Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure J Am Coll Cardiol 43 2004 1439 1444
21. F. Boutitie, F. Gueyffier, S. Pocock for the INDANA Project Steering Committee J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data Ann Internal Med 136 2002 438 448